172 related articles for article (PubMed ID: 226558)
1. Interaction between thyroid-stimulating immunoglobulins and thyrotropin receptors in fat cell membranes.
Kishihara M; Nakao Y; Baba Y; Matsukura S; Kuma K; Fujita T
J Clin Endocrinol Metab; 1979 Nov; 49(5):706-11. PubMed ID: 226558
[TBL] [Abstract][Full Text] [Related]
2. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells.
Kishihara M; Nakao Y; Baba Y; Kobayashi N; Matsukura S; Kuma K; Fujita T
J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672
[TBL] [Abstract][Full Text] [Related]
3. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
[TBL] [Abstract][Full Text] [Related]
4. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
Heyma P; Harrison LC
J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
[TBL] [Abstract][Full Text] [Related]
5. [Studies on the thyrotropin receptor and adenylate cyclase activity in various thyroid diseases: I. The properties of TSH receptor and adenylate cyclase in Graves' thyroid and retro-orbital adipose tissues (author's transl)].
Abe Y
Nihon Naibunpi Gakkai Zasshi; 1980 May; 56(5):739-53. PubMed ID: 6248386
[TBL] [Abstract][Full Text] [Related]
6. Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease.
Shinozawa T; Villadolid MC; Ingbar SH
J Clin Endocrinol Metab; 1986 Jan; 62(1):1-9. PubMed ID: 2999173
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of different assays for the thyroid-stimulating antibody of Graves' disease.
Loeffler M; Zakarija M; McKenzie JM
J Clin Endocrinol Metab; 1983 Sep; 57(3):603-8. PubMed ID: 6135706
[TBL] [Abstract][Full Text] [Related]
8. A new serum-based assay for fat cell-binding immunoglobulins: application to the detection of the thyrotropin receptor antibodies of Graves' disease.
Shinozawa T; Villadolid MC; Ingbar SH
J Clin Endocrinol Metab; 1986 Jan; 62(1):10-5. PubMed ID: 2999174
[TBL] [Abstract][Full Text] [Related]
9. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH
Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357
[TBL] [Abstract][Full Text] [Related]
10. Graves' immunoglobulins protect the human TSH receptor: further evidence for TSH receptor antibodies in Graves' disease.
Davies TF; Platzer M
Clin Endocrinol (Oxf); 1983 Oct; 19(4):427-35. PubMed ID: 6313261
[TBL] [Abstract][Full Text] [Related]
11. Relationship between exophthalmogenic and thyroid-stimulating immunoglobulins in Graves' endocrine ophthalmopathy.
Leövey A; Kálmán K; Szabó T; Lente K; Sándor P; Balázs C
Acta Med Acad Sci Hung; 1980; 37(4):345-50. PubMed ID: 6263033
[TBL] [Abstract][Full Text] [Related]
12. Thyrotropin displacement activity of serum immunoglobulins from patients with Graves' disease.
O'Donnell J; Trokoudes K; Silverberg J; Row V; Volpé R
J Clin Endocrinol Metab; 1978 May; 46(5):770-7. PubMed ID: 233633
[TBL] [Abstract][Full Text] [Related]
13. Correlation between thyrotropin-displacing activity and human thyroid-stimulating activity by immunoglobulins from patients with Graves' disease and other thyroid disorders.
Sugenoya A; Kidd A; Row VV; Volpé R
J Clin Endocrinol Metab; 1979 Mar; 48(3):398-402. PubMed ID: 218990
[TBL] [Abstract][Full Text] [Related]
14. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
[TBL] [Abstract][Full Text] [Related]
15. The use of proteolytic enzyme inhibitor (Trasylol) in radioreceptor assay of TSH-its application to measuring thyroid stimulating immunoglobulins (TSI) in thyroid diseases.
Kishihara M; Nakao Y; Baba Y; Ohgo S; Matsukura S; Kuma K; Imura H
Acta Endocrinol (Copenh); 1978 May; 88(1):65-74. PubMed ID: 77120
[TBL] [Abstract][Full Text] [Related]
16. Thyrotrophin (TSH) binding sites on Yersinia enterocolitica recognized by immunoglobulins from humans with Graves' disease.
Heyma P; Harrison LC; Robins-Browne R
Clin Exp Immunol; 1986 May; 64(2):249-54. PubMed ID: 3017619
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of the Graves' immunoglobulins directed toward the thyrotropin receptor-adenylate cyclase system.
Carayon P; Adler G; Roulier R; Lissitzky S
J Clin Endocrinol Metab; 1983 Jun; 56(6):1202-8. PubMed ID: 6302125
[TBL] [Abstract][Full Text] [Related]
18. Production, isolation, and characterization of rabbit anti-idiotypic antibodies directed against human antithyrotrophin receptor antibodies.
Baker JR; Lukes YG; Burman KD
J Clin Invest; 1984 Aug; 74(2):488-95. PubMed ID: 6086714
[TBL] [Abstract][Full Text] [Related]
19. The species specificity of TSH receptor binding antibodies as measured by radioreceptor study.
Strakosch CR; Joyner D; Manley SW; Wall JR
Clin Endocrinol (Oxf); 1982 Aug; 17(2):173-9. PubMed ID: 6127179
[TBL] [Abstract][Full Text] [Related]
20. Membrane-binding antibodies in patients with Graves' disease and other autoimmune diseases.
Tao TW; Kriss JP
J Clin Endocrinol Metab; 1982 Nov; 55(5):935-40. PubMed ID: 6126489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
